Exane Derivatives’s Royal Gold RGLD Stock Holding History

Exane Derivatives’s Portfolio RGLD Stock Details RGLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$214	Hold	2	–	–	﹤0.01%	668
2022 Q1	$283	Hold	2	–	–	﹤0.01%	928
2021 Q4	$210	Sell	2 -28	-93%	-$2.82K	﹤0.01%	839
2021 Q3	$2.87K	Hold	30	–	–	﹤0.01%	773
2021 Q2	$3.48K	Hold	30	–	–	﹤0.01%	792
2021 Q1	$3.23K	Hold	30	–	–	﹤0.01%	645
2020 Q4	$3.19K	Hold	30	–	–	﹤0.01%	588
2020 Q3	$3.6K	Hold	30	–	–	﹤0.01%	529
2020 Q2	$3.73K	Sell	30 -765	-96%	-$92.4K	﹤0.01%	468
2020 Q1	$69.7K	Buy	795 +525	+194%	+$54.2K	0.02%	326
2019 Q4	$30.9K	Sell	270 -78	-22%	-$9.23K	0.01%	378
2019 Q3	$42.9K	Hold	348	–	–	0.01%	374
2019 Q2	$35.7K	Sell	348 -798	-70%	-$71.9K	0.01%	405
2019 Q1	$104K	Sell	1,146 -409	-26%	-$35.7K	0.02%	291
2018 Q4	$133K	Hold	1,555	–	–	0.02%	291
2018 Q3	$120K	Buy	1,555 +394	+34%	+$32.4K	0.02%	299
2018 Q2	$108K	Buy	1,161 +80	+7%	+$7.16K	0.02%	323
2018 Q1	$89.9K	Sell	1,081 -419	-28%	-$35.3K	0.02%	313
2017 Q4	$123K	Buy	1,500 +1,470	+4,900%	+$126K	0.02%	272
2017 Q3	$2.58K	Hold	30	–	–	﹤0.01%	433
2017 Q2	$2.35K	Buy	+30	New	+$2.26K	﹤0.01%	446
2017 Q1	–	Sell	-30	Closed	-$1.9K	–	656
2016 Q4	$1.9K	Hold	30	–	–	﹤0.01%	450
2016 Q3	$2.32K	Hold	30	–	–	﹤0.01%	462
2016 Q2	$2.16K	Hold	30	–	–	﹤0.01%	405
2016 Q1	$1.54K	Hold	30	–	–	﹤0.01%	466
2015 Q4	$1.09K	Hold	30	–	–	﹤0.01%	400
2015 Q3	$1.41K	Hold	30	–	–	﹤0.01%	412
2015 Q2	$1.85K	Sell	30 -4,519	-99%	-$290K	﹤0.01%	419
2015 Q1	$287K	Sell	4,549 -1,304	-22%	-$89.6K	0.03%	179
2014 Q4	$367K	Buy	+5,853	New	+$384K	0.05%	163

Other funds holding RGLD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Exane Derivatives's RGLD Position: Q2 2022 in Review

Exane Derivatives held its Royal Gold (RGLD) position steady in Q2 2022 at 2 shares worth $214. The position accounts for ﹤0.01% of the portfolio, ranked #668.

Exane Derivatives first reported a position in RGLD in Q4 2014 and has held it in 30 quarters since. The position peaked at $367K in Q4 2014. 413 funds tracked by Wall St. Rank hold RGLD as of Q2 2022.

Exane Derivatives held 2 shares of Royal Gold worth $214 as of Q2 2022.
Exane Derivatives left its Royal Gold share count unchanged in Q2 2022.
Royal Gold made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #668 holding.
Exane Derivatives first reported a position in Royal Gold in Q4 2014 and has held it in 30 quarters since.
Exane Derivatives's Royal Gold position peaked at $367K in Q4 2014.
413 funds tracked by Wall St. Rank held Royal Gold as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.